Histone Deacetylase Inhibitors Globally Enhance H3/H4 Tail Acetylation Without Affecting H3 Lysine 56 Acetylation

Histone deacetylase inhibitors (HDACi) represent a promising avenue for cancer therapy. We applied mass spectrometry (MS) to determine the impact of clinically relevant HDACi on global levels of histone acetylation. Intact histone profiling revealed that the HDACi SAHA and MS-275 globally increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Drogaris, Paul, Villeneuve, Valérie, Pomiès, Christelle, Lee, Eun-Hye, Bourdeau, Véronique, Bonneil, Éric, Ferbeyre, Gerardo, Verreault, Alain, Thibault, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256565/
https://www.ncbi.nlm.nih.gov/pubmed/22355734
http://dx.doi.org/10.1038/srep00220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256565/
https://www.ncbi.nlm.nih.gov/pubmed/22355734
http://dx.doi.org/10.1038/srep00220

Ejemplares similares